Target Jock Itch

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Target Jock Itch
Generic name: CLOTRIMAZOLE 1%
Manufacturer: Target Corporation
Product type: HUMAN OTC DRUG
SPL set ID: f44d4c44-99d1-413f-b9c3-8330bdd21abb
SPL ID: 2d8ce5a3-5900-4e41-8075-ce87a2e350a9
Version: 2
Effective date: 2024-01-17
Source export date: 2026-09-28
Source partition: 3
Source file: https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/fd09911bd1bc81f7f2faeb048e63855fe224e494376ae919a0035190e315c050/drug-label-0003-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:17:52

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M005	openfda.application_number
brand name		Target Jock Itch	openfda.brand_name
generic name		CLOTRIMAZOLE 1%	openfda.generic_name
manufacturer name		Target Corporation	openfda.manufacturer_name
ndc	package	11673-893-14	openfda.package_ndc
ndc	product	11673-893	openfda.product_ndc
ndc11	package	11673089314	derived:openfda.package_ndc
rxcui		309367	openfda.rxcui
spl id		2d8ce5a3-5900-4e41-8075-ce87a2e350a9	id
spl set id		f44d4c44-99d1-413f-b9c3-8330bdd21abb	set_id
unii		G07GZ97H65	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Do not use on children under 2 years of age unless directed by a doctor. When using this product avoid contact with eyes. Stop use and consult a doctor if irritation occurs if there is not improvement within 2 weeks

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.